QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
Log in
CVE:FMS

Focus Graphite Inc. (FMS.V) Competitors

C$0.18
-0.01 (-5.41 %)
(As of 03/4/2021 03:59 PM ET)
Add
Compare
Today's Range
C$0.16
Now: C$0.18
C$0.20
50-Day Range
C$0.00
MA: C$0.14
C$0.25
52-Week Range
C$0.02
Now: C$0.18
C$0.28
Volume2.75 million shs
Average Volume2.75 million shs
Market CapitalizationC$69.69 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Focus Graphite Inc. (FMS.V) (CVE:FMS) Vs. IN, TOS, IOM, HSM, MDP, and PMN

Should you be buying FMS stock or one of its competitors? Companies in the sector of "medical" are considered alternatives and competitors to Focus Graphite Inc. (FMS.V), including InMed Pharmaceuticals Inc. (IN.TO) (IN), TSO3 (TOS), Assure (IOM), Helius Medical Technologies (HSM), Medexus Pharmaceuticals (MDP), and ProMIS Neurosciences (PMN).

Focus Graphite Inc. (FMS.V) (CVE:FMS) and InMed Pharmaceuticals Inc. (IN.TO) (TSE:IN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.

Profitability

This table compares Focus Graphite Inc. (FMS.V) and InMed Pharmaceuticals Inc. (IN.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Focus Graphite Inc. (FMS.V)N/AN/AN/A
InMed Pharmaceuticals Inc. (IN.TO)N/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations for Focus Graphite Inc. (FMS.V) and InMed Pharmaceuticals Inc. (IN.TO), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Focus Graphite Inc. (FMS.V)0000N/A
InMed Pharmaceuticals Inc. (IN.TO)00103.00

Valuation & Earnings

This table compares Focus Graphite Inc. (FMS.V) and InMed Pharmaceuticals Inc. (IN.TO)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Focus Graphite Inc. (FMS.V)N/AN/AN/AC($0.02)-11.67
InMed Pharmaceuticals Inc. (IN.TO)N/AN/AN/AC($1.44)-3.71

Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than InMed Pharmaceuticals Inc. (IN.TO), indicating that it is currently the more affordable of the two stocks.

Summary

InMed Pharmaceuticals Inc. (IN.TO) beats Focus Graphite Inc. (FMS.V) on 2 of the 3 factors compared between the two stocks.

TSO3 (TSE:TOS) and Focus Graphite Inc. (FMS.V) (CVE:FMS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership.

Profitability

This table compares TSO3 and Focus Graphite Inc. (FMS.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
TSO3N/AN/AN/A
Focus Graphite Inc. (FMS.V)N/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for TSO3 and Focus Graphite Inc. (FMS.V), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
TSO30000N/A
Focus Graphite Inc. (FMS.V)0000N/A

Valuation & Earnings

This table compares TSO3 and Focus Graphite Inc. (FMS.V)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TSO3C$3.61 million0.00C$-12,437,096.00C($0.13)N/A
Focus Graphite Inc. (FMS.V)N/AN/AN/AC($0.02)-11.67

Focus Graphite Inc. (FMS.V) has lower revenue, but higher earnings than TSO3. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than TSO3, indicating that it is currently the more affordable of the two stocks.

Summary

TSO3 beats Focus Graphite Inc. (FMS.V) on 2 of the 3 factors compared between the two stocks.

Assure (CVE:IOM) and Focus Graphite Inc. (FMS.V) (CVE:FMS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership.

Profitability

This table compares Assure and Focus Graphite Inc. (FMS.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AssureN/AN/AN/A
Focus Graphite Inc. (FMS.V)N/AN/AN/A

Valuation & Earnings

This table compares Assure and Focus Graphite Inc. (FMS.V)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AssureC$-7,099,000.00-12.44C$-32,080,625.00C($0.63)-2.75
Focus Graphite Inc. (FMS.V)N/AN/AN/AC($0.02)-11.67

Focus Graphite Inc. (FMS.V) has higher revenue and earnings than Assure. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than Assure, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Assure and Focus Graphite Inc. (FMS.V), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Assure0000N/A
Focus Graphite Inc. (FMS.V)0000N/A

Summary

Focus Graphite Inc. (FMS.V) beats Assure on 2 of the 3 factors compared between the two stocks.

Focus Graphite Inc. (FMS.V) (CVE:FMS) and Helius Medical Technologies (TSE:HSM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership.

Profitability

This table compares Focus Graphite Inc. (FMS.V) and Helius Medical Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Focus Graphite Inc. (FMS.V)N/AN/AN/A
Helius Medical TechnologiesN/AN/AN/A

Valuation and Earnings

This table compares Focus Graphite Inc. (FMS.V) and Helius Medical Technologies' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Focus Graphite Inc. (FMS.V)N/AN/AN/AC($0.02)-11.67
Helius Medical TechnologiesC$622,000.0060.34C$-38,078,347.00C($16.48)-0.99

Focus Graphite Inc. (FMS.V) has higher earnings, but lower revenue than Helius Medical Technologies. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Focus Graphite Inc. (FMS.V) and Helius Medical Technologies, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Focus Graphite Inc. (FMS.V)0000N/A
Helius Medical Technologies0000N/A

Summary

Helius Medical Technologies beats Focus Graphite Inc. (FMS.V) on 2 of the 3 factors compared between the two stocks.

Focus Graphite Inc. (FMS.V) (CVE:FMS) and Medexus Pharmaceuticals (CVE:MDP) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations and institutional ownership.

Profitability

This table compares Focus Graphite Inc. (FMS.V) and Medexus Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Focus Graphite Inc. (FMS.V)N/AN/AN/A
Medexus PharmaceuticalsN/AN/AN/A

Valuation & Earnings

This table compares Focus Graphite Inc. (FMS.V) and Medexus Pharmaceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Focus Graphite Inc. (FMS.V)N/AN/AN/AC($0.02)-11.67
Medexus PharmaceuticalsC$108.29 million1.24C$-34,573,801.00C($1.81)-3.88

Focus Graphite Inc. (FMS.V) has higher earnings, but lower revenue than Medexus Pharmaceuticals. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than Medexus Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Focus Graphite Inc. (FMS.V) and Medexus Pharmaceuticals, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Focus Graphite Inc. (FMS.V)0000N/A
Medexus Pharmaceuticals00203.00

Medexus Pharmaceuticals has a consensus price target of C$5.00, indicating a potential downside of 28.77%. Given Medexus Pharmaceuticals' higher possible upside, analysts clearly believe Medexus Pharmaceuticals is more favorable than Focus Graphite Inc. (FMS.V).

Summary

Medexus Pharmaceuticals beats Focus Graphite Inc. (FMS.V) on 4 of the 5 factors compared between the two stocks.

Focus Graphite Inc. (FMS.V) (CVE:FMS) and ProMIS Neurosciences (TSE:PMN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Profitability

This table compares Focus Graphite Inc. (FMS.V) and ProMIS Neurosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Focus Graphite Inc. (FMS.V)N/AN/AN/A
ProMIS NeurosciencesN/AN/AN/A

Valuation & Earnings

This table compares Focus Graphite Inc. (FMS.V) and ProMIS Neurosciences' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Focus Graphite Inc. (FMS.V)N/AN/AN/AC($0.02)-11.67
ProMIS NeurosciencesC$2,767.0012,565.13C$-6,663,813.00C($0.02)-5.22

Focus Graphite Inc. (FMS.V) has higher earnings, but lower revenue than ProMIS Neurosciences. Focus Graphite Inc. (FMS.V) is trading at a lower price-to-earnings ratio than ProMIS Neurosciences, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent recommendations for Focus Graphite Inc. (FMS.V) and ProMIS Neurosciences, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Focus Graphite Inc. (FMS.V)0000N/A
ProMIS Neurosciences0000N/A

Summary

ProMIS Neurosciences beats Focus Graphite Inc. (FMS.V) on 2 of the 3 factors compared between the two stocks.


Focus Graphite Inc. (FMS.V) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
IN
InMed Pharmaceuticals Inc. (IN.TO)
0.6$5.36-9.0%C$43.15 millionN/A-3.71
TSO3 logo
TOS
TSO3
0.5N/AN/AC$40.21 millionC$3.61 million-3.23
IOM
Assure
0.5$1.72-15.7%C$39.84 millionC$-7,099,000.00-2.75Gap Up
HSM
Helius Medical Technologies
0.5$16.24-6.1%C$39.82 millionC$622,000.00-0.99Upcoming Earnings
News Coverage
Gap Up
MDP
Medexus Pharmaceuticals
0.9$7.02-4.3%C$38.66 millionC$108.29 million-3.88Analyst Upgrade
PMN
ProMIS Neurosciences
0.5$0.12-8.3%C$37.67 millionC$2,767.00-5.22High Trading Volume
Gap Up
VIR
Viridium Pacific Group
0.7$0.38-5.3%C$37.54 millionC$1.09 million-2.97Gap Down
COV
Covalon Technologies
0.6$1.68-4.2%C$37.44 millionC$25.80 million-6.22Gap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
0.6$0.29-7.0%C$36.73 millionN/A-2.61Gap Up
META
Meta Growth Corp. (META.V)
0.8$0.14-0.0%C$36.69 millionC$60.96 million-0.66Gap Up
NRTH
48North Cannabis Corp. (NRTH.V)
0.7$0.25-16.0%C$36.44 millionC$13.55 million-0.97High Trading Volume
Emerald Health Therapeutics logo
EMH
Emerald Health Therapeutics
0.5$0.27-5.6%C$34.02 millionC$13.02 million-0.39
SVA
Sernova Corp. (SVA.V)
0.5$1.24-8.9%C$31.35 millionN/A-45.93
IGX
IntelGenx Technologies Corp. (IGX.V)
0.5$0.35-20.0%C$30.87 millionC$822,000.00-4.32Gap Up
NDVA
Indiva
1.1$0.52-5.8%C$27.54 millionC$7.92 million-4.06News Coverage
Gap Down
GEN
GeneNews
0.5N/AN/AC$24.65 millionC$234,592.00-2.21
NLH
Nova Leap Health
0.6$0.69-1.4%C$24.16 millionC$17.64 million-98.57News Coverage
KDA
KDA Group
0.6$0.19-5.3%C$23.68 millionC$22.70 million-12.67Gap Up
Cipher Pharmaceuticals Inc. (CPH.TO) logo
CPH
Cipher Pharmaceuticals Inc. (CPH.TO)
0.8$0.87-1.1%C$23.34 millionC$21.37 million3.07
QPT
Quest PharmaTech
0.8$0.19-0.0%C$21.76 millionC$38,871.000.29Gap Down
CZO
Ceapro
0.7$0.68-2.9%C$21.65 millionC$16.14 million20.61Gap Down
Harvest One Cannabis logo
HVT
Harvest One Cannabis
0.4$0.15-17.2%C$21.51 millionC$8.26 million-0.40Gap Down
EVE
Eve & Co Incorporated
1.0$0.46-2.2%C$21.32 millionC$2.84 million-1.45Gap Down
VIV
Avivagen
0.5$0.56-1.8%C$20.83 millionC$1.18 million-4.75News Coverage
NRI
Nuvo Pharmaceuticals Inc. (NRI.TO)
0.8$1.79-5.0%C$20.39 millionC$76.09 million-2.92
CTX
Crescita Therapeutics
0.6$0.86-1.2%C$17.96 millionC$16.67 million122.86News Coverage
LMD
LED Medical Diagnostics
0.4$0.40-100.0%C$15.51 millionC$14.96 million-10.26Gap Down
KNE
Kane Biotech Inc. (KNE.V)
0.4$0.13-0.0%C$14.12 millionC$1.65 million-2.91
GSD
Devonian Health Group
0.5$0.22-0.0%C$13.96 millionC$1.65 million-3.86Gap Up
PAS
Pascal Biosciences
0.6$0.09-11.1%C$12.70 millionN/A-2.81High Trading Volume
Gap Up
SUGR
SugarBud Craft Growers Corp. (SUGR.V)
0.7$0.08-13.3%C$11.81 millionC$66,906.00-0.07Gap Up
NXG
NexgenRx Inc. (NXG.V)
0.7$0.29-6.9%C$11.19 millionC$10.49 million17.06Gap Up
NSP
Naturally Splendid Enterprises
0.6$0.07-7.7%C$11.06 millionC$2.03 million-1.51
MPH
Medicure
0.7$1.46-2.7%C$10.80 millionC$12.71 million-0.94
BTI
Bioasis Technologies
0.7$0.40-5.0%C$10.16 millionC$4.12 million36.36Gap Down
HEM
Hemostemix Inc. (HEM.V)
0.6$0.42-1.2%C$9.07 millionN/A-2.47Gap Up
NU
NeutriSci International
0.5$0.15-0.0%C$8.65 millionC$69,626.00-11.15Upcoming Earnings
Gap Down
ASG
Aurora Spine
0.6$0.91-3.3%C$8.31 millionC$8.84 million-60.67Gap Up
ICO
iCo Therapeutics Inc. (ICO.V)
0.5$0.11-19.0%C$7.69 millionN/A-8.75Gap Up
RLV
Relevium Technologies
0.5$0.03-16.7%C$6.96 millionC$2.29 million-0.79
IBT
IBEX Technologies
0.7$0.32-0.0%C$6.94 millionC$5.30 million7.50Gap Down
IOT
Innovotech
0.8$0.17-0.0%C$6.52 millionC$1.04 million85.00High Trading Volume
Gap Down
AQS
Aequus Pharmaceuticals
0.9$0.23-11.1%C$6.03 millionC$2.28 million-10.23
VPT
VentriPoint Diagnostics
0.6$0.38-10.5%C$5.58 millionC$37,517.00-11.52Gap Up
VGL
Vigil Health Solutions
0.7$0.35-0.0%C$5.06 millionC$5.43 million20.59
LBL
Lattice Biologics
0.5$0.05-11.1%C$4.67 millionC$2.46 million-3.21News Coverage
BCT
BriaCell Therapeutics
0.5$4.15-2.7%C$4.48 millionN/A-0.80High Trading Volume
IDL
Imaging Dynamics Company Ltd. (IDL.V)
0.4$0.08-6.7%C$4.13 millionC$378,253.00-3.95Gap Up
RVV
Revive Therapeutics
0.5$0.08-12.5%C$3.62 millionN/A-3.64Earnings Announcement
High Trading Volume
Gap Down
MNX
Manitex Capital
0.9$0.92-2.2%C$3.14 millionC$-1,043,068.000.00Gap Down
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.